✦ LIBER ✦

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

✍ Scribed by Jann N. Sarkaria; Evanthia Galanis; Wenting Wu; Patrick J. Peller; Caterina Giannini; Paul D. Brown; Joon H. Uhm; Steven McGraw; Kurt A. Jaeckle; Jan C. Buckner

Book ID: 118455168
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 326 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.05.064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RTOG 0913: A Phase 1 Study of Daily Ever

RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

✍ Chinnaiyan, Prakash; Won, Minhee; Wen, Patrick Y.; Rojiani, Amyn M.; Wendland, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Phase II trial of erlotinib with temozol

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

✍ David M. Peereboom; Dale R. Shepard; Manmeet S. Ahluwalia; Cathy J. Brewer; Neer 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 180 KB

Phase I study of hypofractionated intens

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme

✍ Noha Jastaniyah, Albert Murtha, Nadeem Pervez, Duc Le, Wilson Roa… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 213 KB

Phase II and pharmacogenomics study of e

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

✍ Butowski, N.; Chang, S. M.; Lamborn, K. R.; Polley, M.-Y.; Pieper, R.; Costello, 📂 Article 📅 2011 🏛 Duke University Press 🌐 English ⚖ 173 KB

A phase I study of temozolomide and ever

A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study

✍ Warren P. Mason, Mary MacNeil, Petr Kavan, Jacob Easaw, David Macdonald, Brian T 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 240 KB

Phase I trial with biomarker studies of

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide

✍ Elizabeth R. Gerstner; April F. Eichler; Scott R. Plotkin; Jan Drappatz; Colin L 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 244 KB